Skip to main content
FinSpry Logo
FinSpry
SPRO logo
SPRO
(NASDAQ)
Spero Therapeutics, Inc.
$1.16-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Spero Therapeutics (SPRO) Stock Price & Financial Analysis

Spero Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.10 - $1.28
52-Week High$3.08
52-Week Low$1.50
Open$1.28
Volume3.70M
Average Volume (3M)1.95M
Market Cap72.75M
Shares Outstanding57.28M
P/E Ratio (TTM)5.90
Price to Sales (P/S)1.64
Price to Book (P/B)1.70
EV/EBITDA2.50
Revenue (TTM)54.77M
Net Income (TTM)15.23M
Free Cash Flow (TTM)7.24M
EPS (TTM)$0.27
Profit Margin27.82%
Operating Margin25.89%
Return on Equity (ROE)28.78%
Debt to Equity0.05
50-Day MA$2.45
200-Day MA$2.41
52-Week Change-36.69%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Spero Therapeutics

What is the current stock price for SPRO?

As of the latest trading session, SPRO stock trades at $1.16. The 52-week range is $1.50–$3.08, with a day range of $1.10–$1.28.

What is the P/E ratio for SPRO?

Spero Therapeutics's trailing P/E ratio is 5.9, meaning investors pay $5.9 for every $1 of annual earnings. Spero Therapeutics operates in the Healthcare sector.

Does SPRO pay dividends?

Spero Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SPRO?

Analyst ratings and recommendations for SPRO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of SPRO?

Spero Therapeutics's market capitalization is $66.4M, classifying it as a micro-cap company. Spero Therapeutics operates in the Healthcare sector within the Biotechnology industry.